These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Rhino-orbitocerebral mucormycosis attributable to Apophysomyces elegans in an immunocompetent individual: case report and review of the literature. Garcia-Covarrubias L; Bartlett R; Barratt DM; Wassermann RJ J Trauma; 2001 Feb; 50(2):353-7. PubMed ID: 11242306 [No Abstract] [Full Text] [Related]
46. Management of rhino-orbital mucormycosis. Mohamed MS; Abdel-Motaleb HY; Mobarak FA Saudi Med J; 2015 Jul; 36(7):865-8. PubMed ID: 26108594 [TBL] [Abstract][Full Text] [Related]
47. Use of posaconazole in the treatment of infective rhinocerebral mucormycosis. Kulendra K; Habibi M; Butler C; Clarke P; Howard D J Laryngol Otol; 2010 Dec; 124(12):1314-7. PubMed ID: 20388246 [TBL] [Abstract][Full Text] [Related]
48. Rhino-orbital-cerebral-mucormycosis in COVID-19: A systematic review. Bhattacharyya A; Sarma P; Sharma DJ; Das KK; Kaur H; Prajapat M; Kumar S; Bansal S; Prakash A; Avti P; Thota P; Reddy DH; Gautam BS; Medhi B Indian J Pharmacol; 2021; 53(4):317-327. PubMed ID: 34414911 [TBL] [Abstract][Full Text] [Related]
49. Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis. Reed C; Ibrahim A; Edwards JE; Walot I; Spellberg B Antimicrob Agents Chemother; 2006 Nov; 50(11):3968-9. PubMed ID: 17000743 [No Abstract] [Full Text] [Related]
51. Current treatments against mucormycosis and future directions. Smith C; Lee SC PLoS Pathog; 2022 Oct; 18(10):e1010858. PubMed ID: 36227854 [TBL] [Abstract][Full Text] [Related]
52. Invasive rhino-orbital fungal sinusitis following dental manipulation. Chopra H; Dua K; Bhatia S; Dua N; Mittal V Mycoses; 2009 Jul; 52(4):368-71. PubMed ID: 18705660 [TBL] [Abstract][Full Text] [Related]
53. Mucormycosis: More Than Meets the Eye! Ally MT; Jenkins IH; Gupta V Am J Med; 2019 Sep; 132(9):1044-1046. PubMed ID: 31047865 [No Abstract] [Full Text] [Related]
54. [Rhino-Orbital Mucormycosis. Cohort study of its treatment according disease extent and reversion of its pathophysiology]. Prado-Calleros HM; Fajardo-Dolci G; Plowes-Hernández O; Jiménez-Gutiérrez C Gac Med Mex; 2016; 152(6):770-782. PubMed ID: 27861475 [TBL] [Abstract][Full Text] [Related]
55. Successful Treatment of Rhino-Orbital-Cerebral Mucormycosis in a Child With Leukemia. Jensen TSR; Arendrup MC; von Buchvald C; Frandsen TL; Juhler M; Nygaard U J Pediatr Hematol Oncol; 2017 May; 39(4):e211-e215. PubMed ID: 27841827 [TBL] [Abstract][Full Text] [Related]
56. Rhino-orbital mucormycosis in acute renal failure. Ray MS; Kumar V; Jain D; Dubey NK Indian Pediatr; 2002 Apr; 39(4):381-5. PubMed ID: 11976470 [No Abstract] [Full Text] [Related]
57. Successful treatment of rhino-orbital mucormycosis by a new combination therapy with liposomal amphotericin B and micafungin. Ogawa T; Takezawa K; Tojima I; Shibayama M; Kouzaki H; Ishida M; Okabe H; Shimizu T Auris Nasus Larynx; 2012 Apr; 39(2):224-8. PubMed ID: 21592699 [TBL] [Abstract][Full Text] [Related]
58. Palatal mucormycosis in a patient with SARS-CoV-2 infection. Venugopal A; Marya A CMAJ; 2021 Aug; 193(32):E1254. PubMed ID: 34400485 [No Abstract] [Full Text] [Related]
59. Rhino-orbito-cerebral mucormycosis: report of two cases and review of the literature. Haliloglu NU; Yesilirmak Z; Erden A; Erden I Dentomaxillofac Radiol; 2008 Mar; 37(3):161-6. PubMed ID: 18316508 [TBL] [Abstract][Full Text] [Related]